| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762514242P | 2017-06-02 | 2017-06-02 | |
| US201862663082P | 2018-04-26 | 2018-04-26 |
| Publication Number | Publication Date |
|---|---|
| SG10201913194WAtrue SG10201913194WA (en) | 2020-03-30 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201913194WASG10201913194WA (en) | 2017-06-02 | 2018-05-31 | Recombinant robo2 proteins, compositions, methods and uses thereof |
| Country | Link |
|---|---|
| US (2) | US10906955B2 (en) |
| EP (1) | EP3630808A1 (en) |
| JP (2) | JP7018458B2 (en) |
| KR (1) | KR20200016292A (en) |
| CN (1) | CN110709415A (en) |
| AU (2) | AU2018278809B2 (en) |
| BR (1) | BR112019024742A2 (en) |
| CA (1) | CA3006926A1 (en) |
| CO (1) | CO2019013315A2 (en) |
| IL (1) | IL270917A (en) |
| MX (1) | MX2019014480A (en) |
| PE (1) | PE20200495A1 (en) |
| PH (1) | PH12019502717A1 (en) |
| SG (1) | SG10201913194WA (en) |
| TW (1) | TW201902920A (en) |
| WO (1) | WO2018222850A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112195154B (en)* | 2019-07-08 | 2024-03-29 | 江苏汇智生物科技有限公司 | Cell for genetically modifying and expressing modified PLA2R receptor and application thereof |
| WO2025045139A1 (en)* | 2023-08-31 | 2025-03-06 | 舒泰神（北京）生物制药股份有限公司 | Antibody specifically recognizing robo2 and use thereof |
| TW202511284A (en)* | 2023-09-14 | 2025-03-16 | 大陸商北京拓界生物醫藥科技有限公司 | Protein comprising robo domains and the pharmaceutical use thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| ATE245190T1 (en) | 1997-10-20 | 2003-08-15 | Univ California | ROBO: A FAMILY OF POLYPEPTIDES AND NUCLEIC ACIDS EFFECTIVE IN NERVE CELL CONDUCTION |
| WO2003075860A2 (en) | 2002-03-08 | 2003-09-18 | Abgent, Inc. | Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
| WO2005063815A2 (en) | 2003-11-12 | 2005-07-14 | Biogen Idec Ma Inc. | Fcϝ receptor-binding polypeptide variants and methods related thereto |
| KR20090114443A (en)* | 2007-02-09 | 2009-11-03 | 제넨테크, 인크. | Anti-RWF4 antibodies and uses thereof |
| FR2958936A1 (en) | 2010-04-14 | 2011-10-21 | Sanofi Aventis | ROBO1-FC FUSION PROTEIN AND ITS USE IN THE TREATMENT OF TUMORS |
| AU2011347250B2 (en)* | 2010-12-23 | 2015-06-04 | Sanofi | Robo1-Fc fusion protein for use in the treatment of hepatocarcinoma |
| EP2800578B1 (en)* | 2012-01-05 | 2018-12-05 | Boston Medical Center Corporation | Slit-robo signaling for diagnosis and treatment of kidney disease |
| JP2013230115A (en)* | 2012-04-27 | 2013-11-14 | Daiichi Sankyo Co Ltd | Anti-robo4 antibody |
| EP2862580A4 (en)* | 2012-06-15 | 2016-06-01 | Asan Foundation | COMPOSITION FOR THE PREVENTION OR TREATMENT OF A FRACTURE OR OSTEOPOROSIS USING A SLIT-ROBO SYSTEM |
| EP3137506B1 (en)* | 2014-05-02 | 2023-08-30 | Momenta Pharmaceuticals, Inc. | Compositions and methods related to engineered fc constructs |
| WO2016001810A1 (en)* | 2014-07-01 | 2016-01-07 | Pfizer Inc. | Bispecific heterodimeric diabodies and uses thereof |
| US20180282410A1 (en)* | 2015-10-02 | 2018-10-04 | Hoffmann-La Roche Inc. | Anti-cd3xrob04 bispecific t cell activating antigen binding molecules |
| Publication number | Publication date |
|---|---|
| KR20200016292A (en) | 2020-02-14 |
| US10906955B2 (en) | 2021-02-02 |
| EP3630808A1 (en) | 2020-04-08 |
| RU2019143457A (en) | 2021-07-09 |
| JP2020522248A (en) | 2020-07-30 |
| US20180346542A1 (en) | 2018-12-06 |
| WO2018222850A8 (en) | 2019-11-21 |
| TW201902920A (en) | 2019-01-16 |
| US20210214414A1 (en) | 2021-07-15 |
| PE20200495A1 (en) | 2020-03-04 |
| CN110709415A (en) | 2020-01-17 |
| AU2018278809B2 (en) | 2022-03-31 |
| IL270917A (en) | 2020-01-30 |
| AU2018278809A1 (en) | 2019-11-21 |
| JP7018458B2 (en) | 2022-02-10 |
| CO2019013315A2 (en) | 2020-04-01 |
| MX2019014480A (en) | 2020-01-23 |
| RU2019143457A3 (en) | 2021-11-02 |
| JP7315637B2 (en) | 2023-07-26 |
| CA3006926A1 (en) | 2018-12-02 |
| AU2022204368A1 (en) | 2022-07-14 |
| BR112019024742A2 (en) | 2020-06-16 |
| PH12019502717A1 (en) | 2020-10-19 |
| JP2022033727A (en) | 2022-03-02 |
| US11970524B2 (en) | 2024-04-30 |
| WO2018222850A1 (en) | 2018-12-06 |
| Publication | Publication Date | Title |
|---|---|---|
| IL268588A (en) | Anti-gprc5d antibodies, compositions comprising same and uses thereof | |
| IL262497A (en) | Anti-il-33 antibodies, compositions, methods and uses thereof | |
| IL283754A (en) | Anti-claudin antibodies, compositions comprising same and uses thereof | |
| IL257030A (en) | Multivalent and multispecific gitr-binding fusion proteins, compositions comprising same and uses thereof | |
| ZA201707749B (en) | Compounds targeting proteins, compositions, methods, and uses thereof | |
| IL274297A (en) | Pyrazolo-piperidine substituted indole-2-carboxamides, compositions comprising same and uses thereof | |
| IL260530B1 (en) | Multivalent and multispecific 41bb-binding fusion proteins, compositions ocmprising same and uses thereof | |
| EP3347472A4 (en) | Compositions comprising cyp76ad1- clade polypeptides and uses thereof | |
| EP3268050A4 (en) | Pore-forming protein conjugate compositions and methods | |
| IL265796A (en) | Compositions comprising pedf-derived short peptides and uses thereof | |
| IL266526A (en) | Recombinant virus, composition comprising the same, and uses thereof | |
| IL275435B (en) | Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof | |
| EP3642219A4 (en) | Peptide compositions and related methods | |
| IL237852A0 (en) | Anti amphiregulin antibodies, compositions comprising same and uses thereof | |
| GB201707248D0 (en) | Modified complement proteins and uses thereof | |
| IL257434A (en) | Mrka polypeptides, antibodies, and uses thereof | |
| IL270917A (en) | Recombinant robo2 proteins, compositions, methods and uses thereof | |
| IL263842A (en) | Tatk -cdkl5 fusion proteins, compositions, formulations, and use thereof | |
| ZA202003722B (en) | Modified globin proteins | |
| ZA201805797B (en) | Novel alpha-1-microglobulin derived proteins and their use | |
| IL277632A (en) | C-terminal cdnf fragments, pharmaceutical compositions comprising same and uses thereof | |
| GB201704006D0 (en) | Modified globin proteins | |
| IL269751A (en) | Proteins derived from clpb and uses thereof | |
| IL268971B1 (en) | Polypeptide, polypeptide fragment, derivative thereof, and applications thereof | |
| EP3268042A4 (en) | Anti-tnf-alpha polypeptide composition and use thereof |